NUZ 2.17% 23.5¢ neurizon therapeutics limited

Pharmaust Phase II K9 Trial, page-170

  1. 3,268 Posts.
    lightbulb Created with Sketch. 273
    What are people's thoughts on the potential failure of the next phase of trials. Surely this will now pump on official news that the trial is starting, but does this company have a plan or plans if the trial is unsuccessful
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.